Creation of the Pfizer-FRQS Innovation Fund for Alzheimer's Disease and Related Disorders
MONTREAL, June 28, 2012 /CNW Telbec/ - Pfizer Canada and the Fonds de recherche du Québec - Santé (FRQS) are today announcing the creation of the Pfizer-FRQS Innovation
Fund for Alzheimer's Disease and Related Disorders, thanks to $4.5
million in funding from Pfizer Canada. This FRQS-managed research grant
program will be available to Quebec's research community.
There are two parts to the Pfizer-FRQS Innovation Fund for Alzheimer's
Disease and Related Disorders. One involves the creation of a
consortium of Quebec researchers, while the other is devoted to the
funding of high-risk, high-spinoff-potential projects to enable
researchers to explore new avenues of research.
"The purpose of creating this fund is to mobilize Quebec researchers, to
provide them with an infrastructure that will enable them, among other
things, to set up an Alzheimer's patient data registry. It will also
make it possible to conduct innovative research for better
understanding the mechanisms underlying this disease by exploring
research hypotheses that have so far never been investigated. Pfizer
Canada's financial support is extremely valuable because it provides a
unique opportunity to further our knowledge of this disease, which is
having a considerable impact on Quebec society," says Claude Lazure,
Ph.D., the FRQS's acting scientific director.
"Pfizer Canada is proud to have been partnering with the FRQS since
2008. Over the past 4 years, the Pfizer-FRQS Innovation Fund has held
four competitions and funded 10 large projects in areas such as cancer,
AIDS and personalized medicine," notes Allen Van der Wee, General
Manager of Pfizer's Primary Business Unit Canada. "Setting up this fund
for Alzheimer's disease is part of a broader Pfizer strategy for
partnering with the FRQS to meet health needs identified in the Quebec
population and is therefore enabling Quebec's life sciences sector to
bolster its presence and global leadership".
Quebec, Canada and many other countries in the world recognize
Alzheimer's disease as a health intervention priority both in terms of
prevention, care and research. In this respect, Quebec has had, since
May of 2009, the report entitled "Meeting the Challenge of Alzheimer's
Disease and Related Disorders: A Vision Focused on the Individual,
Humanism, and Excellence", which makes a series of 24 recommendations,
from raising awareness to research.
Details of the Pfizer-FRQS Innovation Fund for Alzheimer's Disease and
Related Disorders program will be announced in July on the FRQS's
website at www.frqs.gouv.qc.ca.
About the Fonds de recherche du Québec - Santé (FRQS)
The mission of the Fonds de recherche du Québec - Santé (FRQS), which reports to the Minister of Economic Development,
Innovation and Export Trade, is to support health research to foster
the wellness of Quebec's population. Its mandate is to promote and
financially support such research, to disseminate knowledge and train
researchers, to forge partnerships necessary for the development of
Quebec's research and innovation system, and, lastly, to advance
research internationally. The FRQS supports 11 groups, 19 centres and
18 thematic research networks. For further information, visit www.frqs.gouv.qc.ca.
About Pfizer in Canada
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., the world's
leading biopharmaceutical company. The company is one of the largest
contributors to health research in Canada. Our diversified health care
portfolio includes biologic and small molecule medicines and vaccines
for humans and animals, and many of the world's best-known consumer
products. Every day, Pfizer Canada employees work to advance wellness,
prevention, treatments and cures that challenge the most feared
diseases of our time. We apply science and our global resources to
improve the health and well-being of Canadians at every stage of life.
Our commitment is reflected in everything Pfizer does, from our disease
awareness initiatives to our community partnerships, to our belief that
it takes more than medication to be truly healthy. To learn more about
Pfizer's More than Medication philosophy and programs, visit morethanmedication.ca. To learn more about Pfizer Canada, visit www.pfizer.ca.
SOURCE PFIZER CANADA INC.
For further information:
Communications and Knowledge Mobilization
Fonds de recherche du Québec
Telephone: 514-873-2114, ext. 1235